A very-low-calorie diet (VLCD) intervention for the management of prediabetes and early Type 2 diabetes mellitus in a multi-ethnic cohort in Aotearoa New Zealand: The PROGRESS NZ feasibility study

被引:0
|
作者
Whitfield, Patricia Louise [1 ,2 ]
Hall, Rosemary Megan [1 ,2 ]
Theaude, Lorene [1 ]
Sixtus, Ryan Phillip [1 ]
Kanaan, Rami [1 ]
Holley, Ana Simone [1 ]
Umpleby, A. Margot [3 ]
Weatherall, Mark [1 ]
Rowlands, David Stephen [4 ]
Krebs, Jeremy David [1 ,2 ]
机构
[1] Univ Otago, Dept Med, Wellington Campus,21A Mein St, Wellington 6021, New Zealand
[2] Wellington Hosp, Endocrine Diabet & Res Ctr, Wellington, New Zealand
[3] Univ Surrey, Sch Biosci & Med, Guildford, England
[4] Massey Univ, Sch Sport Exercise & Nutr, Palmerston North, New Zealand
关键词
Key Words: VLCD; very-low calorie diet; Type; 2; diabetes; prediabetes; New Zealand; HEPATIC GLUCOSE-PRODUCTION; BETA-CELL FUNCTION; INSULIN SENSITIVITY; WEIGHT-LOSS; ENERGY RESTRICTION; PACIFIC;
D O I
暂无
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background and Objectives: Very-low calorie diets (VLCD) achieve weight loss and remission of Type 2 diabetes (T2DM), but efficacy and acceptability in non-European populations is less clear. This feasibility study examines the impact of 10% weight loss through VLCD on metabolic and body composition outcomes in a multiethnic cohort of Aotearoa New Zealand (AoNZ) men with prediabetes/early T2DM, and VLCD tolerability/cultural acceptability. Methods and Study Design: Participants followed a VLCD intervention (mean energy 3033kJ/day) until achievement of 10% weight loss. An oral glucose tolerance test (OGTT), hyperinsulinaemic isoglycaemic clamp with stable isotopes, hood calorimetry and dual-energy Xray absorptiometry (DXA) were undertaken before and after intervention. Qualitative data on VLCD tolerability/cultural acceptability were collected. Results: Fifteen participants were enrolled; nine achieved 10% weight loss. In this group, mean HbA1c reduced by 4.8mmol/mol (2.4-7.1) and reverted to normoglycaemia in n=5/9; mean body weight reduced by 12.0 kg (11.0-13.1) and whole-body glucose disposal improved by 1.5 mg kgFFM-1 min-1 (0.7-2.2). Blood pressure and fasting triglycerides improved significantly. No changes in hepatic glucose metabolism were found. In all participants who attended completion testing, HbA1c reduced by 3.4mmol/mol (SD 3.5) and total weight by 9.0kg (SD 5.7). The intervention was highly tolerable/culturally acceptable however challenges with fulfilment of cultural obligations were described. Conclusions: Results support VLCD use in AoNZ however further work to investigate ethnic differences in physiological response to VLCDs and to optimise protocols for multi-ethnic populations are required.
引用
收藏
页码:200 / 212
页数:13
相关论文
共 1 条
  • [1] Association between within-target risk factors and life expectancy free from cardiovascular disease, cancer, and dementia in individuals with type 2 diabetes in New Zealand between 1994 and 2018: a multi-ethnic cohort study
    Yu, Dahai
    Zhao, Zhanzheng
    Pickering, Karen
    Baker, John
    Cutfield, Richard
    Orr-Walker, Brandon J.
    Sundborn, Gerhard
    Wang, Zheng
    Cai, Yamei
    Fu, Hang
    Wang, Chengzeng
    Simmons, David
    BMC MEDICINE, 2024, 22 (01):